Search filters

List of works by Kathy Wolski

Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis

scientific article published in December 2005

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

scientific article

Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

scientific article

Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy

scientific article published in September 2004

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

scientific article published on November 2002

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

scientific article published on 01 December 2002

Planned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Per

Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

scientific article (publication date: 2004)

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

scientific article (publication date: October 2003)

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial

scientific article published in June 2005

Paulina is supported by:

About Paulina

Help